BioLASCO Taiwan Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	258.04	262.66	292.5	264.72	235.91	227.58
Revenue Growth	-8.71%	-10.20%	10.49%	12.21%	3.66%	-23.86%
Cost of Revenue	156.35	157.89	177.74	160.37	131.43	122.47
Gross Profit	101.69	104.78	114.76	104.35	104.49	105.11
Selling, General & Admin	55.81	56.66	59.06	53.54	55.22	51.18
Operating Expenses	55.81	56.73	59.02	53.59	55.22	51.21
Operating Income	45.88	48.04	55.74	50.76	49.27	53.89
Interest Expense	-2.12	-2.03	-1.76	-1.3	-1.09	-0.88
Interest & Investment Income	1.5	1.61	2.41	1.83	0.73	0.47
Earnings From Equity Investments	1.23	0.81	1.72	8.72	4.68	2.72
Currency Exchange Gain (Loss)	-	-	0.18	0.31	-0.52	0.2
Other Non Operating Income (Expenses)	1.31	1.13	0.28	1.66	0.05	0.04
EBT Excluding Unusual Items	47.81	49.56	58.56	61.99	53.14	56.44
Other Unusual Items	-	-	-3.64	-	-	-
Pretax Income	47.81	49.56	54.92	61.99	53.14	56.44
Income Tax Expense	6.92	7.14	10.89	12.25	10.83	11.29
Earnings From Continuing Operations	40.89	42.43	44.03	49.74	42.31	45.15
Net Income	40.89	42.43	44.03	49.74	42.31	45.15
Net Income to Common	40.89	42.43	44.03	49.74	42.31	45.15
Net Income Growth	-16.08%	-3.63%	-11.49%	17.57%	-6.29%	-28.10%
Shares Outstanding (Basic)	26	26	26	26	26	26
Shares Outstanding (Diluted)	26	26	26	26	26	26
Shares Change	-0.07%	0.24%	-0.02%	-0.00%	-0.02%	-0.03%
EPS (Basic)	1.59	1.65	1.72	1.94	1.65	1.76
EPS (Diluted)	1.59	1.65	1.72	1.94	1.65	1.76
EPS Growth	-16.25%	-4.02%	-11.39%	17.58%	-6.25%	-28.16%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	33.73	27.06	1.04	27.83	40.88	66.62
Free Cash Flow Per Share	1.31	1.05	0.04	1.08	1.59	2.60
Dividend Per Share	-	-	1.500	1.650	1.500	1.600
Dividend Growth	-	-	-9.09%	10.00%	-6.25%	-20.00%
Gross Margin	39.41%	39.89%	39.23%	39.42%	44.29%	46.18%
Operating Margin	17.78%	18.29%	19.06%	19.18%	20.88%	23.68%
Profit Margin	15.85%	16.15%	15.05%	18.79%	17.94%	19.84%
Free Cash Flow Margin	13.07%	10.30%	0.35%	10.51%	17.33%	29.27%
EBITDA	58.75	59.58	64.45	58.96	56.91	62.07
EBITDA Margin	22.77%	22.68%	22.04%	22.27%	24.12%	27.27%
D&A For EBITDA	12.87	11.53	8.71	8.2	7.64	8.18
EBIT	45.88	48.04	55.74	50.76	49.27	53.89
EBIT Margin	17.78%	18.29%	19.06%	19.18%	20.88%	23.68%
Effective Tax Rate	14.46%	14.40%	19.83%	19.76%	20.38%	20.00%